| Aspergillosis Detection Via EBC-GM in Ventilated Patients | Non-Invasive Detection of Aspergillosis in Ventilated Patients: Galactomannan Analysis in Exhaled Breath | NCT06333379 |
| Multicenter Performance Evaluation of Galactomannan Antigen and (1,3)-ß -D-glucan Chemiluminescence Enzyme Immunoassay for the Diagnosis of Invasive Fungal Disease | Multicenter Performance Evaluation of Galactomannan Antigen and (1,3)-ß -D-glucan Chemiluminescence Enzyme Immunoassay for the Diagnosis of Invasive Fungal Disease | ChiCTR2300073796 |
| A Study of Hydroxypropyl Guar Galactomannan 0.25% (HPGG) Versus Vehicle in Dry Eye Patients | | NCT00840268 |
| Novel treatment for pollen-food allergy syndrome using hypoallergenic pollen | Novel allergen immunotherapy for pollen-food allergy syndrome using birch pollen-galactomannan conjugate | JPRN-jRCTs031230008 |
| Carbohydrate ProLectin M, a Gelectin-3 Antagonist to block SARS-CoV2 Activity | Guar gum Galactomannan- PROlectin M, a nucleocapsid TErminal GaleCTin antagonist for COVID-19 (PROTECT), a Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety among asymptomatic to moderately-severe, ambulatory patients | CTRI/2022/03/040757 |
| The influence of Galactomannan detection on tube feeding ß-galactomannan in critically ill patients: a prospective randomized controlled clinical trial | The influence of Galactomannan detection on tube feeding ß-galactomannan in critically ill patients: a prospective randomized controlled clinical trial | ChiCTR2100049888 |
| Glycemic Response of Foods with Fenupower and Foods without Fenupower | Effect of Fenupower (Galactomannan extract from fenugreek seed) on glycemic index of selected Indian foods | CTRI/2017/05/008579 |
| Randomized, controlled, double-blinded clinical trial of oral Cry j1-galactomannan conjugate immunotherapy for Japanese cedar pollen allergy | Randomized, controlled, double-blinded clinical trial of oral Cry j1-galactomannan conjugate immunotherapy for Japanese cedar pollen allergy - RCT of Cry j1-galactomannan conjugate OIT for Japanese cedar pollen allergy | JPRN-UMIN000011995 |
| Anti-tumoral vaccination of melanoma patients with peptides associated with GM-CT-01, a vegetal derived sugar that binds to and blocks galectin, a protein produced by tumor cells that inhibits immune cells. | Phase I/II study of peptide vaccination associated with GM-CT-01, a galactomannan oligomer that inhibits galestin-3, in patients with advanced metastatic melanoma - Peptide vaccinations plus GM-CT-01 in melanoma | EUCTR2010-018638-29-BE |
| To Determine Whether Galactomannan Test Will Help to Detect Fungal Infections Early and Hence Start Treatment Early | Using Serum Galactomannan Levels in a Prospective, Randomised, Non-blinded Trial to Guide Early Anti-fungal Therapy in Haematology Patients at Risk of Invasive Aspergillosis. | NCT00361517 |
| a prospective, randomized, open study of oral Cry j1-galactomannan conjugate immunotherapy for Japanese cedar pollen allergy | a prospective, randomized, open study of oral Cry j1-galactomannan conjugate immunotherapy for Japanese cedar pollen allergy - an open study of Cry j1-galactomannan conjugate OIT for Japanese cedar pollen allergy | JPRN-UMIN000013408 |
